News & Updates

In the EMERALD-1 trial, durvalumab plus bevacizumab (D+B) combined with transarterial chemoembolization (TACE) improved progression-free survival (PFS) in individuals with unresectable hepatocellular carcinoma (HCC) eligible for embolization.

The presence of folic acid in plasma and intake of folic acid supplements appear to contribute to chemotherapy-induced toxicities in patients treated with capecitabine for colorectal cancer (CRC), reports a recent study.

Women who regularly consume dairy products do not have an increased risk of developing breast cancer, reveals a study. However, there is heterogeneity seen for the type of dairy food, period of life, and tumour subtypes.